Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intranasal Insulin for Prevention of Type 1 Diabetes in Children Carrying Increased HLA-Conferred Genetic Risk

NCT00223613 is registered in ClinicalTrials.gov with University of Turku as lead sponsor.

NCT NCT00223613
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00223613 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intranasal Insulin for Prevention of Type 1 Diabetes in Children Carrying Increased HLA-Conferred Genetic Risk
Lead sponsor
University of Turku
Phase
Phase 3
Overall status
Unknown status
Start date
August 31, 1997
Completion date
August 31, 2005
Enrollment
240
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

type 1 diabetes